PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections

Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Fungi (Basel)
Asıl Yazarlar: Murray, Alison, Cass, Lindsey, Ito, Kazuhiro, Pagani, Nicole, Armstrong-James, Darius, Dalal, Paras, Reed, Anna, Strong, Pete
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/
https://ncbi.nlm.nih.gov/pubmed/33348852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller